According to the latest market report published by the company titled ‘Sarcopenia Treatment Market<\/strong>: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026,’ the globalsarcopenia treatment marketis projected to reachUS$ 3,302.0 Mn<\/strong>by theend of 2026<\/strong>and grow at aCAGR of 4.2%<\/strong>during the forecast period.<\/p>\n Global Sarcopenia Treatment Market: Dynamics<\/strong><\/p>\n Sarcopenia is categorized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 the muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia among people aged 65 years and above is estimated to be 15%, whereas 50% among people aged 80 and above.<\/p>\n Get Sample Copy of Report @https:\/\/www.persistencemarketresearch.com\/samples\/15694<\/a><\/strong><\/p>\n Company Profiles<\/strong><\/p>\n Increasing consumption of dietary and nutritional supplements due to health consciousness among the elderly population is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiency is expected to boost the growth of the sarcopenia treatment market.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n Most of the pharmaceutical and food-processing companies are investing in the development of new nutrition supplements in order to focus on the specific needs. Likewise, increasing investments in nutraceutical development is the major factor expected to spur the growth of the sarcopenia treatment market.<\/p>\n Get To Know Methodology of Report @https:\/\/www.persistencemarketresearch.com\/methodology\/15694<\/a><\/strong><\/p>\n The growth of the sarcopenia treatment market is primary driven by the increasing aging population. According to the National Institutes of Health (NIH), the global population of people aged 80 and above is expected to grow from 126.5 million to 446.6 million between 2015 and 2050.<\/p>\n Reduction of hormone secretion rate and increasing vitamin deficiency with aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as the rise in consumer spending by the aging population and increasing per capita healthcare expenditure are also expected to drive the demand for sarcopenia treatment supplements.<\/p>\n According to the National Health Expenditure Accounts (NHEA), the U.S. health care spending grew by4.3% in 2016<\/strong>, reachingUS$ 3.3 trillion or US$ 10,348 per person<\/strong>.<\/p>\n However, the diagnosis rate of sarcopenia is very low as a large number of people ignore the symptoms of muscle loss. Moreover, low awareness regarding diagnostic and management methods of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market.<\/p>\n Moreover, unavailability of sarcopenia treatment drugs and the high cost of protein supplement are the other factors expected to restrain the growth of the sarcopenia treatment market.<\/p>\n Global Sarcopenia Treatment Market: Forecast<\/strong><\/p>\n The global sarcopenia treatment market is segmented based on treatment type, distribution channel, and region. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin D & calcium supplement, and vitamin B12 supplement.<\/p>\n The protein supplement segment is expected to represent a high revenue share in the global sarcopenia treatment market over the forecast period.<\/p>\n Based on the distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket & supermarket. Among all the distribution channels, the retail pharmacies is expected to be the leading segment in the global sarcopenia treatment market over the forecast period.<\/p>\n The online pharmacies segment is expected to represent a high growth rate in the global sarcopenia treatment market due to increasing online purchasing and manufacturer’s inclination towards digital platforms for marketing and sale.<\/p>\n On the basis of region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.<\/p>\n This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the sarcopenia treatment in specific regions. North America is expected to contribute a high revenue share in the global sarcopenia treatment market over the forecast period.<\/p>\n Access Full Report @https:\/\/www.persistencemarketresearch.com\/checkout\/15694<\/a><\/strong><\/p>\n The demand for sarcopenia treatment has increased in North America due to the increasing adoption of nutritional supplements, particularly by the elderly population due to increasing health consciousness. Europe is expected to account second large share in the global sarcopenia treatment market over the forecast period.<\/p>\n The developed European countries, such as Germany, the U.K., France, and Italy, are expected to account high share in the Europe sarcopenia treatment market due to increasing sarcopenia prevalence associated with inactive lifestyle and obesity. The Asia Pacific is expected to witness rapid growth in the global sarcopenia treatment market over the forecast period due to increasing aging population in countries such as Japan.<\/p>\n<\/div>\n Explore Extensive Coverage of PMR`sLife Sciences & Transformational Health<\/a>Landscape<\/strong><\/p>\n Molecular Diagnostics Market –<\/strong><\/p>\n Molecular Diagnostics Market<\/a>Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.<\/p>\n Next-Generation Sequencing Market –<\/strong><\/p>\n Next Generation Sequencing Market<\/a>Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.<\/p>\n Ophthalmology devises Market –<\/strong><\/p>\n Ophthalmology devises Market<\/a>Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.<\/p>\n Intravenous Iron Drugs Market –<\/strong><\/p>\n Intravenous (IV) Iron Drugs Market<\/a>Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A\/S, Rockwell Medical Technologies, Inc., and Sanofi.<\/p>\n Syndromes Progressive Ataxia Weakness Disorders Market –<\/strong><\/p>\n Treatments forSyndromes of Progressive Ataxia and Weakness Disorders Market<\/a>Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.<\/p>\n About us:<\/strong><\/p>\n Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.<\/p>\n To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.<\/p>\n Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.<\/p>\n Contact us:<\/strong><\/p>\n 305 Broadway, 7th Floor Tags: Sarcopenia Treatment Market Demand<\/a>, Sarcopenia Treatment Market Development<\/a>, Sarcopenia Treatment Market Forecast<\/a>, Sarcopenia Treatment Market Growth<\/a>, Sarcopenia Treatment Market Revenue Share<\/a>, Sarcopenia Treatment Market Size<\/a>, Sarcopenia Treatment Market Supply<\/a>, Sarcopenia Treatment Market Trends<\/a>, Sarcopenia Treatment Market Analysis<\/a><\/p>\n 305 Broadway, 7th Floor Tags:<\/b> 305 Broadway, 7th Floor![\"sarcopenia](\"https:\/\/www.persistencemarketresearch.com\/images\/sarcopenia-treatment-market.jpg\" "\\"Sarcopenia")
<\/p>\n\n
\nNew York City, NY 10007
\nUnited States
\nPh.no. +1-646-568-7751
\nE-mail id-sales@persistencemarketresearch.com<\/a>
\nWebsite:https:\/\/www.persistencemarketresearch.com<\/a><\/p>\n
Contact Information:<\/b><\/p>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n
<\/a>, Extended Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
Contact Information:<\/h3>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/04\/4027-1588089731.png\")
According to the latest market report published by the company titled ‘Sarcopenia Treatment Market: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026,’ the global sarcopenia treatment market is projected to reach US$ 3,302.0 Mn by the end of 2026 and grow at a CAGR of 4.2% during the forecast period. Global Sarcopenia Treatment Market: Dynamics Sarcopenia is categorized by progressive … Continue reading Sarcopenia Treatment Market to Register CAGR 4.2% Growth in Revenue During the Forecast Period 2026<\/span><\/a> Continue Reading
<\/p>\n